Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

Older patients with CAD scheduled for TAVR have comparable outcomes regardless of whether they undergo PCI before TAVR.

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A ...

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

Supira Medical announced today that it received FDA approval to initiate a new trial of its percutaneous ventricular assist ...

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump ...

Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during ...